Literature DB >> 19064997

Secreted trefoil factor 2 activates the CXCR4 receptor in epithelial and lymphocytic cancer cell lines.

Zinaida Dubeykovskaya1, Alexander Dubeykovskiy, Joel Solal-Cohen, Timothy C Wang.   

Abstract

The secreted trefoil factor family 2 (TFF2) protein contributes to the protection of the gastrointestinal mucosa from injury by strengthening and stabilizing mucin gels, stimulating epithelial restitution, and restraining the associated inflammation. Although trefoil factors have been shown to activate signaling pathways, no cell surface receptor has been directly linked to trefoil peptide signaling. Here we demonstrate the ability of TFF2 peptide to activate signaling via the CXCR4 chemokine receptor in cancer cell lines. We found that both mouse and human TFF2 proteins (at approximately 0.5 microm) activate Ca2+ signaling in lymphoblastic Jurkat cells that could be abrogated by receptor desensitization (with SDF-1alpha) or pretreatment with the specific antagonist AMD3100 or an anti-CXCR4 antibody. TFF2 pretreatment of Jurkat cells decreased Ca2+ rise and chemotactic response to SDF-1alpha. In addition, the CXCR4-negative gastric epithelial cell line AGS became highly responsive to TFF2 treatment upon expression of the CXCR4 receptor. TFF2-induced activation of mitogen-activated protein kinases in gastric and pancreatic cancer cells, KATO III and AsPC-1, respectively, was also dependent on the presence of the CXCR4 receptor. Finally we demonstrate a distinct proliferative effect of TFF2 protein on an AGS gastric cancer cell line that expresses CXCR4. Overall these data identify CXCR4 as a bona fide signaling receptor for TFF2 and suggest a mechanism through which TFF2 may modulate immune and tumorigenic responses in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19064997      PMCID: PMC2635042          DOI: 10.1074/jbc.M804935200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

1.  Characterization of a putative receptor for intestinal trefoil factor in rat small intestine: identification by in situ binding and ligand blotting.

Authors:  X D Tan; W Hsueh; H Chang; K R Wei; F Gonzalez-Crussi
Journal:  Biochem Biophys Res Commun       Date:  1997-08-28       Impact factor: 3.575

2.  Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsets: rapid internalization and recycling upon activation.

Authors:  R Förster; E Kremmer; A Schubel; D Breitfeld; A Kleinschmidt; C Nerl; G Bernhardt; M Lipp
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

3.  Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis.

Authors:  C P Tran; G A Cook; N D Yeomans; L Thim; A S Giraud
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

4.  Distribution and metabolism of intravenously administered trefoil factor 2/porcine spasmolytic polypeptide in the rat.

Authors:  S S Poulsen; J Thulesen; E Nexø; L Thim
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

5.  Phosphorylation of beta-catenin and epidermal growth factor receptor by intestinal trefoil factor.

Authors:  D Liu; I el-Hariry; A J Karayiannakis; J Wilding; R Chinery; W Kmiot; P D McCrea; W J Gullick; M Pignatelli
Journal:  Lab Invest       Date:  1997-12       Impact factor: 5.662

6.  N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities.

Authors:  P Loetscher; J H Gong; B Dewald; M Baggiolini; I Clark-Lewis
Journal:  J Biol Chem       Date:  1998-08-28       Impact factor: 5.157

7.  Oral human spasmolytic polypeptide protects against aspirin-induced gastric injury in rats.

Authors:  G A Cook; L Thim; N D Yeomans; A S Giraud
Journal:  J Gastroenterol Hepatol       Date:  1998-04       Impact factor: 4.029

8.  Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats.

Authors:  M W Babyatsky; M deBeaumont; L Thim; D K Podolsky
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

9.  Spontaneous and ligand-induced trafficking of CXC-chemokine receptor 4.

Authors:  N I Tarasova; R H Stauber; C J Michejda
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

10.  Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4.

Authors:  D Schols; S Struyf; J Van Damme; J A Esté; G Henson; E De Clercq
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

View more
  36 in total

1.  Trefoil factor family peptide 2 acts pro-proliferative and pro-apoptotic in the murine retina.

Authors:  Adnana N Paunel-Görgülü; Andreas G Franke; Friedrich P Paulsen; Nicole Dünker
Journal:  Histochem Cell Biol       Date:  2011-04-22       Impact factor: 4.304

Review 2.  Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.

Authors:  M P Rettig; G Ansstas; J F DiPersio
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

3.  TFF2-CXCR4 Axis Is Associated with BRAF V600E Colon Cancer.

Authors:  Manish K Gala; Thomas Austin; Shuji Ogino; Andrew T Chan
Journal:  Cancer Prev Res (Phila)       Date:  2015-04-21

4.  Stromal cell-derived factor-1 overexpression induces gastric dysplasia through expansion of stromal myofibroblasts and epithelial progenitors.

Authors:  Wataru Shibata; Hiroshi Ariyama; Christoph Benedikt Westphalen; Daniel L Worthley; Sureshkumar Muthupalani; Samuel Asfaha; Zinaida Dubeykovskaya; Michael Quante; James G Fox; Timothy C Wang
Journal:  Gut       Date:  2012-02-23       Impact factor: 23.059

Review 5.  Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Authors:  Nayara Braga Emidio; Stuart M Brierley; Christina I Schroeder; Markus Muttenthaler
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-09

6.  Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis.

Authors:  Thiruvengadam Arumugam; Will Brandt; Vijaya Ramachandran; Tood T Moore; Huamin Wang; Felicity E May; Bruce R Westley; Rosa F Hwang; Craig D Logsdon
Journal:  Pancreas       Date:  2011-08       Impact factor: 3.327

7.  Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations.

Authors:  Chen Wu; Xiaoping Miao; Liming Huang; Xu Che; Guoliang Jiang; Dianke Yu; Xianghong Yang; Guangwen Cao; Zhibin Hu; Yongjian Zhou; Chaohui Zuo; Chunyou Wang; Xianghong Zhang; Yifeng Zhou; Xianjun Yu; Wanjin Dai; Zhaoshen Li; Hongbing Shen; Luming Liu; Yanling Chen; Sheng Zhang; Xiaoqi Wang; Kan Zhai; Jiang Chang; Yu Liu; Menghong Sun; Wei Cao; Jun Gao; Ying Ma; Xiongwei Zheng; Siu Tim Cheung; Yongfeng Jia; Jian Xu; Wen Tan; Ping Zhao; Tangchun Wu; Chengfeng Wang; Dongxin Lin
Journal:  Nat Genet       Date:  2011-12-11       Impact factor: 38.330

Review 8.  CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.

Authors:  Hyo Jin Lee; Ik-Chan Song; Hwan-Jung Yun; Deog-Yeon Jo; Samyong Kim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

9.  Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.

Authors:  Junpei Yamaguchi; Mari Mino-Kenudson; Andrew S Liss; Sanjib Chowdhury; Timothy C Wang; Carlos Fernández-Del Castillo; Keith D Lillemoe; Andrew L Warshaw; Sarah P Thayer
Journal:  Gastroenterology       Date:  2016-08-12       Impact factor: 22.682

10.  Trefoil Factor 2 Promotes Type 2 Immunity and Lung Repair through Intrinsic Roles in Hematopoietic and Nonhematopoietic Cells.

Authors:  Li-Yin Hung; Taylor K Oniskey; Debasish Sen; Matthew F Krummel; Andrew E Vaughan; Noam A Cohen; De'Broski R Herbert
Journal:  Am J Pathol       Date:  2018-02-16       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.